Buzdar A U, Singletary S E, Booser D J, Frye D K, Wasaff B, Hortobagyi G N
University of Texas M.D. Anderson Cancer Center, Houston, USA.
Surg Oncol Clin N Am. 1995 Oct;4(4):715-34.
Seven hundred fifty-two patients with stage III disease (of those, 178 patients with inflammatory carcinoma) were treated with a combined modality approach at our institute in seven prospective studies. After three to four cycles of chemotherapy, each patient was treated with local therapy. An estimated 54% of patients with stage IIIA disease and 24% of patients with stage IIIB disease were free of disease. An estimated 30% of patients with inflammatory carcinoma of breast were free of disease beyond 10 years with this approach.
在我们研究所进行的七项前瞻性研究中，752例III期疾病患者（其中178例为炎性癌患者）接受了综合治疗。经过三到四个周期的化疗后，每位患者接受局部治疗。估计IIIA期疾病患者中有54%、IIIB期疾病患者中有24%无疾病。采用这种方法，估计30%的乳腺炎性癌患者在10年以上无疾病。
